Alland Leila — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Alland Leila has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $157K.

Profile

Leila Alland is a director at Abeona Therapeutics Inc. (ABEO) as disclosed in the SEC filing with CIK 0001825216 dated 2026-01-27. In her role, she participates in the governance and oversight of Abeona, a clinical-stage biopharmaceutical company focused on gene therapies and plasma-based products for life-threatening rare genetic diseases.

Board memberships

• Abeona Therapeutics Inc.

Awards & honors

• Director at Abeona Therapeutics Inc.
• Participates in governance and oversight of a clinical-stage biopharmaceutical company

Recent Transactions

Companies — Last 90 Days

• ABEONA THERAPEUTICS INC. (ABEO) — 1 filings, last 2026-07-02

Frequently Asked Questions

Who is Alland Leila?

Leila Alland is a director at Abeona Therapeutics Inc. (ABEO) as disclosed in the SEC filing with CIK 0001825216 dated 2026-01-27. In her role, she participates in the governance and oversight of Abeona, a clinical-stage biopharmaceutical company focused on gene therapies and plasma-based products for life-threatening rare genetic diseases.…

How many SEC Form 4 filings has Alland Leila submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Alland Leila been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($157K) across all tracked filings.

Where can I see all of Alland Leila's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week